| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.73▲ | 0.73▼ | 0.73▼ | 0.74▼ | 3.00▼ |
| MA10 | 0.73▼ | 0.72▲ | 0.72▲ | 1.83▼ | 3.54▼ |
| MA20 | 0.73▼ | 0.72▲ | 0.73▲ | 3.04▼ | 3.52▼ |
| MA50 | 0.72▲ | 0.74▼ | 1.05▼ | 3.73▼ | 2.93▼ |
| MA100 | 0.72▲ | 1.31▼ | 2.68▼ | 3.56▼ | 3.31▼ |
| MA200 | 0.73▼ | 2.77▼ | 3.52▼ | 2.98▼ | 6.80▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.006▲ | 0.047▲ | -0.346▼ | -0.342▼ |
| RSI | 49.500▼ | 46.602▼ | 27.602▼ | 23.000▼ | 28.467▼ |
| STOCH | 12.266▼ | 79.252 | 65.812 | 1.322▼ | 46.447 |
| WILL %R | -83.929▼ | -32.192 | -32.192 | -98.765▼ | -98.915▼ |
| CCI | -72.926 | 50.882 | 48.330 | -68.206 | -275.005▼ |
|
Wednesday, December 17, 2025 05:51 AM
Vistagen (VTGN) stock in focus as the company's social anxiety disorder therapy fasedienol fails in a Phase 3 trial. Read more here.
|
|
Thursday, November 13, 2025 02:56 PM
VistaGen Therapeutics, Inc. (VTGN) came out with a quarterly loss of $0.54 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to a loss of $0.42 per share a year ago.
|
|
Thursday, August 07, 2025 04:21 PM
VistaGen Therapeutics, Inc. (VTGN) came out with a quarterly loss of $0.47 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.35 per share a year ago. These figures are ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/12/25 | 0.7258 | 0.747 | 0.682 | 0.7284 | 2,670,232 |
| 24/12/25 | 0.71 | 0.7439 | 0.7033 | 0.7279 | 1,772,506 |
| 23/12/25 | 0.75 | 0.75 | 0.7062 | 0.7131 | 3,292,868 |
| 22/12/25 | 0.78 | 0.8388 | 0.748 | 0.748 | 5,940,007 |
| 19/12/25 | 0.70 | 0.78 | 0.68 | 0.78 | 7,413,500 |
| 18/12/25 | 0.8218 | 0.8423 | 0.7301 | 0.74 | 10,393,723 |
| 17/12/25 | 0.8827 | 0.968 | 0.75 | 0.861 | 72,078,539 |
| 16/12/25 | 4.38 | 4.50 | 4.30 | 4.36 | 603,800 |
| 15/12/25 | 4.29 | 4.48 | 4.16 | 4.39 | 990,497 |
| 12/12/25 | 3.99 | 4.37 | 3.96 | 4.25 | 676,551 |
|
|
||||
|
|
||||
|
|